FDA Inspection 1152943 — OneBlood, Inc.

OneBlood, Inc. — FEI 1045422

The FDA completed an inspection of OneBlood, Inc. on September 2, 2021 in St Petersburg, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 2, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
St Petersburg, FL (United States)